Tracking lung cancer treatment evolution in France since 2015

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compiles data from electronic medical records of lung cancer patients treated at 38 hospitals across France, including comprehensive cancer centers and public hospitals. It focuses on collecting detailed information about patient demographics, tumor characteristics, treatment protocols, and clinical events. Trained technicians gather and harmonize this data using a centralized electronic data collection tool, ensuring that all information is anonymized and aggregated for analysis. The aim is to create a comprehensive database that reflects real-world treatment outcomes and trends in lung cancer care.

Why it matters

Who can join: the full rules

Inclusion criteria :

* Adult (over 18)
* Treated (with radiotherapy or systemic anti-cancer treatment) for a lung cancer or diagnosed with metastatic lung cancer over the selection period at one of the participating site

Exclusion criteria

\- None

Where it's running

• Institut de Cancérologie de l'Ouest - Paul Papin
  Angers, France Recruiting
• Institut Bergonié
  Bordeaux, France Recruiting
• Centre François Baclesse
  Caen, France Recruiting
• Centre Jean Perrin
  Clermont-Ferrand, France Recruiting
• Hôpital Intercommunal de Créteil
  Créteil, France Recruiting
• Centre Georges-François Leclerc
  Dijon, France Recruiting

Study contacts

• Study coordinator: Lise Bosquet, MsC
• Email: l-bosquet@unicancer.fr
• Phone: 0033668642660

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

• Olive oil before lung cancer surgery to see if it lowers chylothorax

  This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.

  Recruiting Fudan University · Shanghai, Xuhui · NCT07807696

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.